Evidence map›Paper›PMID 33302345›Full record

ArticleBiomedicines2020

Verbascoside Protects Pancreatic β-Cells against ER-Stress.

Alessandra Galli, Paola Marciani, Algerta Marku, Silvia Ghislanzoni, Federico Bertuzzi, Raffaella Rossi, Alessia Di Giancamillo, Michela Castagna, Carla Perego

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 45 citations in OpenAlex.

  1. Blue LED photobiomodulation in the prevention of radiodermatitis in breast cancer survivors: a clinical trial.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Quality, Safety and Biological Studies onPharmaceuticals (Basel, Switzerland) · 2023
    Article
  15. Foods (Basel, Switzerland) · 2023
    Article
  16. Bioactive Compounds ofBiomolecules · 2023
    Review
  17. The pharmacokinetic property and pharmacological activity of acteoside: A review.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
    Review
  18. Pharmaceuticals (Basel, Switzerland) · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Alessandra GalliDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20134 Milan, Italy.
Paola MarcianiDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20134 Milan, Italy.
Algerta MarkuDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20134 Milan, Italy.
Silvia GhislanzoniDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20134 Milan, Italy.
Federico BertuzziDiabetology Unit, Niguarda Hospital, 20162 Milan, Italy.
Raffaella RossiDepartment of Veterinary Medicine, Università degli Studi di Milano, 26900 Lodi, Italy.
Alessia Di GiancamilloDepartment of Veterinary Medicine, Università degli Studi di Milano, 26900 Lodi, Italy.ORCID 0000-0003-1674-3020
Michela CastagnaDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20134 Milan, Italy.ORCID 0000-0001-8144-9173
Carla PeregoDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20134 Milan, Italy.ORCID 0000-0003-3027-1779
University of Milan · ITAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Substantial epidemiological evidence indicates that a diet rich in polyphenols protects against developing type 2 diabetes. The phenylethanoid glycoside verbascoside/acteoside, a widespread polyphenolic plant compound, has several biological properties including strong antioxidant, anti-inflammatory and neuroprotective activities. The aim of this research was to test the possible effects of verbascoside on pancreatic β-cells, a target never tested before. Mouse and human β-cells were incubated with verbascoside (0.8-16 µM) for up to five days and a combination of biochemical and imaging techniques were used to assess the β-cell survival and function under normal or endoplasmic reticulum (ER)-stress inducing conditions. We found a dose-dependent protective effect of verbascoside against oxidative stress in clonal and human β-cells. Mechanistic studies revealed that the polyphenol protects β-cells against ER-stress mediated dysfunctions, modulating the activation of the protein kinase RNA-like endoplasmic reticulum kinase (PERK) branch of the unfolded protein response and promoting mitochondrial dynamics. As a result, increased viability, mitochondrial function and insulin content were detected in these cells. These studies provide the evidence that verbascoside boosts the ability of β-cells to cope with ER-stress, an important contributor of β-cell dysfunction and failure in diabetic conditions and support the therapeutic potential of verbascoside in diabetes.

Indexed as

anti-inflammatorydiabetesER-stressinsulin-producing cellsmitochondriaoxidative stressPERKpolyphenolsUPRverbascoside

Identifiers

PMID33302345
PMCPMC7762434
OpenAlexW3110846230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.